Perrigo Completes Divestiture Of Generic Rx Business For $1.55 Billion
DUBLIN, July 6, 2021 |PRNewswire| -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Consumer Self-Care Products, announced today that it has completed the previously announced sale of its Generic Rx Pharmaceuticals business to
Perrigo Completes Divestiture Of Generic Rx Business For $1.55 Billion
DUBLIN, July 6, 2021 |PRNewswire| -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Consumer Self-Care Products, announced today that it has completed the previously announced sale of its Generic Rx Pharmaceuticals business to